- Home
- CIVB vs VSTM Comparison
CIVB vs VSTM Comparison
Compare CIVB & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIVB | VSTM |
|---|---|---|
| Founded | 1884 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.3M | 470.7M |
| IPO Year | 2012 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CIVB | VSTM |
|---|---|---|
| Price | $25.56 | $4.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $26.60 | $16.50 |
| AVG Volume (30 Days) | 51.4K | ★ 2.1M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | ★ 31.34 | 17.49 |
| EPS | ★ 0.72 | N/A |
| Revenue | $19,023,000.00 | ★ $30,914,000.00 |
| Revenue This Year | $14.88 | $282.64 |
| Revenue Next Year | $5.99 | $72.25 |
| P/E Ratio | $35.50 | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $18.95 | $4.00 |
| 52 Week High | $26.15 | $11.25 |
Technical Indicators
Market Signals| Indicator | CIVB | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 58.66 | 35.18 |
| Support Level | $21.39 | $4.00 |
| Resistance Level | $25.99 | $6.67 |
| Average True Range (ATR) | 0.68 | 0.26 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 70.21 | 23.00 |
Price Performance
Historical ComparisonAbout CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.